Junjiang Sun

1.3k total citations
41 papers, 1.0k citations indexed

About

Junjiang Sun is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Junjiang Sun has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Molecular Biology and 18 papers in Hematology. Recurrent topics in Junjiang Sun's work include Virus-based gene therapy research (20 papers), Hemophilia Treatment and Research (18 papers) and CAR-T cell therapy research (13 papers). Junjiang Sun is often cited by papers focused on Virus-based gene therapy research (20 papers), Hemophilia Treatment and Research (18 papers) and CAR-T cell therapy research (13 papers). Junjiang Sun collaborates with scholars based in United States, China and France. Junjiang Sun's co-authors include Paul E. Monahan, R. Jude Samulski, Chengwen Li, Matthew L. Hirsch, Zhijian Wu, Terry Van Dyke, Fang Yin, Chaoying Yin, Taiping Zhang and Tal Kafri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Junjiang Sun

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjiang Sun United States 18 617 583 239 229 101 41 1.0k
Hengjun Chao United States 11 737 1.2× 706 1.2× 103 0.4× 318 1.4× 59 0.6× 17 994
Sandra Powell United States 12 408 0.7× 652 1.1× 171 0.7× 195 0.9× 83 0.8× 17 1.0k
Sergio Vai Italy 6 702 1.1× 663 1.1× 65 0.3× 369 1.6× 77 0.8× 6 971
Gilda F. Linton United States 15 420 0.7× 407 0.7× 263 1.1× 347 1.5× 91 0.9× 24 1.1k
Irene Gil-Fariña Germany 10 368 0.6× 420 0.7× 50 0.2× 131 0.6× 54 0.5× 24 617
Paritha Arumugam United States 20 317 0.5× 502 0.9× 161 0.7× 105 0.5× 50 0.5× 36 1.1k
Shing Jen Tai United States 7 1.7k 2.8× 1.5k 2.5× 321 1.3× 724 3.2× 121 1.2× 10 2.1k
Maria Carmina Castiello Italy 17 305 0.5× 320 0.5× 74 0.3× 174 0.8× 64 0.6× 27 785
Anna Shcherbina Russia 18 196 0.3× 253 0.4× 357 1.5× 102 0.4× 55 0.5× 107 1.0k
Amber Miller United States 14 208 0.3× 330 0.6× 77 0.3× 233 1.0× 57 0.6× 29 714

Countries citing papers authored by Junjiang Sun

Since Specialization
Citations

This map shows the geographic impact of Junjiang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjiang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjiang Sun more than expected).

Fields of papers citing papers by Junjiang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjiang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjiang Sun. The network helps show where Junjiang Sun may publish in the future.

Co-authorship network of co-authors of Junjiang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Junjiang Sun. A scholar is included among the top collaborators of Junjiang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjiang Sun. Junjiang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenjun, Adalberto Luiz Rosa, Richard F. Loeser, et al.. (2025). Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy. UNC Libraries.
2.
Li, Wenjun, Junjiang Sun, Adalberto Luiz Rosa, et al.. (2025). Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy. Frontiers in Immunology. 16. 1527858–1527858. 1 indexed citations
3.
Hua, Baolai, et al.. (2024). Anti-inflammatory effect of a novel piperazino-enaminone delivered by liposomes in a mouse model of hemophilic arthropathy. International Journal of Pharmaceutics. 659. 124291–124291. 1 indexed citations
4.
Sun, Junjiang, Linchao Zhang, Rui Liu, et al.. (2024). Effect of Mo nanoparticles on microstructure and mechanical properties of Cu alloys by self-propagating and spark plasma sintering. Materials Science and Engineering A. 916. 147305–147305. 9 indexed citations
5.
Li, Wenjun, Junjiang Sun, Feng Wang, et al.. (2023). Intra-articular delivery of AAV vectors encoding PD-L1 attenuates joint inflammation and tissue damage in a mouse model of rheumatoid arthritis. Frontiers in Immunology. 14. 1116084–1116084. 10 indexed citations
6.
He, Xijing, Zhenjie Zhang, Junyi Xue, et al.. (2022). Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response. Nature Communications. 13(1). 7275–7275. 29 indexed citations
7.
Shao, Wenwei, Junjiang Sun, Xiaojing Chen, et al.. (2022). Chimeric Mice Engrafted With Canine Hepatocytes Exhibits Similar AAV Transduction Efficiency to Hemophilia B Dog. Frontiers in Pharmacology. 13. 815317–815317. 2 indexed citations
8.
Jiang, Wei, et al.. (2021). Repeated Systemic Dosing of Adeno-Associated Virus Vectors in Immunocompetent Mice After Blockade of T Cell Costimulatory Pathways. Human Gene Therapy. 33(5-6). 290–300. 13 indexed citations
9.
Li, Min, et al.. (2020). Exploring the Potential Feasibility of Intra-Articular Adeno-Associated Virus-Mediated Gene Therapy for Hemophilia Arthropathy. Human Gene Therapy. 31(7-8). 448–458. 6 indexed citations
10.
Sun, Junjiang, Eric W. Livingston, Peter Johansen, et al.. (2019). Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding. Journal of Thrombosis and Haemostasis. 17(8). 1240–1246. 1 indexed citations
11.
Sun, Junjiang, et al.. (2019). Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model. Inflammation. 42(5). 1719–1729. 2 indexed citations
12.
Sun, Junjiang, Wenwei Shao, Xiaojing Chen, et al.. (2018). An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Molecular Therapy — Methods & Clinical Development. 10. 257–267. 27 indexed citations
15.
Monahan, Paul E., Clinton D. Lothrop, Junjiang Sun, et al.. (2010). Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application. Molecular Therapy. 18(11). 1907–1916. 98 indexed citations
16.
Chen, Shufen, Junjiang Sun, Vivian W. Choi, et al.. (2010). VHL and PTEN loss coordinate to promote mouse liver vascular lesions. Angiogenesis. 13(1). 59–69. 7 indexed citations
17.
Monahan, Paul E. & Junjiang Sun. (2010). Hemophilic Synovitis: Factor VII and the Potential Role of Extravascular Factor VIIa. Thrombosis Research. 125. S63–S66. 1 indexed citations
18.
Rehman, Hasibur, Junjiang Sun, Yanjun Shi, et al.. (2010). NIM811 Prevents Mitochondrial Dysfunction, Attenuates Liver Injury, and Stimulates Liver Regeneration After Massive Hepatectomy. Transplantation. 91(4). 406–412. 41 indexed citations
19.
Wu, Zhijian, Junjiang Sun, Taiping Zhang, et al.. (2007). Optimization of Self-complementary AAV Vectors for Liver-directed Expression Results in Sustained Correction of Hemophilia B at Low Vector Dose. Molecular Therapy. 16(2). 280–289. 129 indexed citations
20.
Patriarca, Giampiero, Claudio D’Ambrosio, Domenico Schiavino, et al.. (1999). Allergy to Betalactams. International Archives of Allergy and Immunology. 118(2-4). 247–250. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026